A Study to Investigate Mocertatug Rezetecan With Bevacizumab Compared With Platinum Doublet With Bevacizumab in Participants With Platinum-sensitive Ovarian Cancer (BEHOLD-Ovarian02)
3d agoen
From the article
Conditions : Ovarian Neoplasms Interventions : Drug: Mocertatug rezetecan (Mo-Rez); Drug: Carboplatin; Drug: Paclitaxel; Drug: Gemcitabine; Drug: Pegylated liposomal doxorubicin (PLD); Drug: Bevacizumab Sponsors : GlaxoSmithKline; ENGOT, GOG, APGOT Not yet recruiting
Continue reading on clinicaltrials.govYou might also wanna read
Una nueva terapia logra atacar el cáncer de ovario reduciendo el daño a las células sanas
Infobae·3d ago
CRIS Contra el Cáncer financia una nueva estrategia de terapias dirigidas frente al cáncer de ovario
Infobae·2d ago
Ovarian cancer drug mirvetuximab improves quality of life for patients, UK women report
A new ovarian cancer drug called mirvetuximab is offering women more time and a better quality of life compared to standard chemotherapy. Pa
bbc.co.uk·1mo agoReal-World EV Plus Pembro Success Seen in Urothelial Cancer
Medscape·1d ago
Ovarian Stimulation With Letrozole Shows No Short-Term Molecular Impact on Breast Tumors 2026
OncoDaily·15h ago
Durvalumab plus HAIC-FOLFOX followed by maintenance durvalumab for hepatocellular carcinoma with major portal invasion: phase 2 DurHope study
doi.org·18d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.